PLASMODIUM FALCIPARUM INFECTION
Clinical trials for PLASMODIUM FALCIPARUM INFECTION explained in plain language.
Never miss a new study
Get alerted when new PLASMODIUM FALCIPARUM INFECTION trials appear
Sign up with your email to follow new studies for PLASMODIUM FALCIPARUM INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot antibody shields kids from malaria in landmark trial
Disease control CompletedThis study tested a single injection of an antibody called L9LS in healthy Kenyan children aged 5 months to 10 years. The goal was to see if it safely protects against malaria infection caused by the Plasmodium falciparum parasite. The trial involved 912 children and was complete…
Matched conditions: PLASMODIUM FALCIPARUM INFECTION
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New study Fine-Tunes malaria drug dosing for kids
Knowledge-focused CompletedThis completed study looked at how the malaria drug artesunate works in 90 Ugandan children aged 6 months to 14 years with severe malaria. Researchers measured drug levels in the blood and tracked vital signs like temperature and blood pressure to see how the body responds. The g…
Matched conditions: PLASMODIUM FALCIPARUM INFECTION
Phase: PHASE4 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC